Business Context and Reporting Period
This Form 8-K filing by Glucotrack, Inc. (GCTK) reports on corporate governance changes effective October 6, 2023, and October 11, 2023. The company is incorporated in Delaware and trades on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive personnel changes and does not contain financial performance data.
Material Changes
- Resignation: Jolie Kahn resigned as Chief Financial Officer effective October 6, 2023, to pursue other career interests. The resignation was not due to any disagreement with the Company regarding operations, policies, or accounting practices.
- Appointment: James S. Cardwell was appointed Chief Financial Officer effective October 11, 2023.
Management Commentary and Compensation
James S. Cardwell brings over 16 years of experience as a CFO and COO, with a focus on SEC financial reporting and tax compliance. His background includes interim CFO roles at various public companies including NanoVibronix, Inc. and Esports Entertainment Group.
Mr. Cardwell entered into a one-year consulting agreement with the Company. His compensation is set at a minimum of $1,500 per month. The agreement allows either party to terminate the arrangement with 30 days' written notice.
Investor Verification Checklist
- Verify the transition timeline between the resignation of the former CFO and the appointment of the new CFO.
- Review the full text of the Cardwell Consulting Agreement (Exhibit 10.1) for additional terms not summarized in the filing.
- Confirm the impact of the leadership change on upcoming financial reporting cycles.